From July 1, 2024 to July 17, 2024, the company has repurchased 9,267,705 shares, representing 1.58% for CNY 20.73 million. With this, the company has completed the repurchase of 14,703,805 shares, representing 2.5% for CNY 33.74 million under the buyback announced on April 19, 2024.
Qinghai Spring Medicinal Resources Technology Co., Ltd.
Equities
600381
CNE0000017W0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.74 CNY | +4.98% |
|
+27.44% | -64.55% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-64.55% | 211M | |
+7.30% | 4.81B | |
-31.08% | 3.6B | |
-0.71% | 3.09B | |
-24.32% | 2.62B | |
-11.35% | 2.27B | |
+34.19% | 1.82B | |
+33.49% | 1.41B | |
-15.07% | 1.38B | |
+40.95% | 1.37B |
- Stock Market
- Equities
- 600381 Stock
- News Qinghai Spring Medicinal Resources Technology Co., Ltd.
- Tranche Update on Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback Plan announced on April 19, 2024.